Paratek Pharmaceuticals (PRTK) Q4 2020 Earnings Call Transcr

Paratek Pharmaceuticals (PRTK) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to the Paratek Pharmaceuticals fourth-quarter and full-year 2020 earnings conference call. [Operator instructions] As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host, Ben Strain, vice president of investor relations. Please go ahead, sir.
Ben Strain --
Vice President of Investor Relations
Good afternoon, and welcome to Paratek's fourth-quarter and full-year 2020 earnings and corporate update conference call. A press release for the company's fourth-quarter and full-year results was issued earlier today, and we've also posted slides on our website that will be referred to on this call. Both can be found at www.paratekpharma.com. Participants on today's call are Evan Loh, CEO; Adam Woodrow, president and chief commercial officer; Randy Brenner, chief development and regulatory officer; Michael Bigham, executive chairman; and Sarah Higgins, vice president of finance, controller, and principal accounting officer, will also be available for questions.

Related Keywords

United States , China , White House , District Of Columbia , Evan Loh , Adam Woodrow , Randy Brenner , Sarah Higgins , Michael Bigham , Zai Lab To Paratek , Paratek Pharmaceuticals , Zai Lab , Strategic National , Scientific Congress , Ben Strain , R Bridge Healthcare Investment , Zai Lab Related , Chief Commercial , Essential Medicines List , ஒன்றுபட்டது மாநிலங்களில் , சீனா , வெள்ளை வீடு , மாவட்டம் ஆஃப் கொலம்பியா , எவன் லோ , ஆடம் வூட்ரோ , ரேண்டி ப்ரென்னர் , சாரா ஹிக்கின்ஸ் , மைக்கேல் பிக்ஹாம் , ஜா ஆய்வகம் , மூலோபாய தேசிய , அறிவியல் காங்கிரஸ் , பென் திரிபு , ர் பாலம் சுகாதாரம் முதலீடு , ஜா ஆய்வகம் தொடர்புடையது , தலைமை வணிகரீதியானது , அவசியம் மருந்துகள் பட்டியல் ,

© 2025 Vimarsana